Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine
Clinical trial NCT04389073 · UNKNOWN
Trial details
- NCT number
- NCT04389073
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-01
- Primary completion
- 2022-12-31
- Enrollment
- 138
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.